Skip to content
Screener

AYTU BioPharma, Inc. AYTU Q1 2026 earnings

Reported September 22, 2026 · After market close

Revenue$16.1MBeat by $3.8M
EPS-$0.05Beat by $0.24
Revenue estimate$12.3M
EPS estimate-$0.29

Next report

Nov 12, 2026 (in a month)
Revenue estimate$13.3M
EPS estimate-$0.26

FAQ

When did AYTU BioPharma, Inc. report Q1 2026 earnings?
AYTU BioPharma, Inc. (AYTU) reported Q1 2026 earnings on September 22, 2026 after market close.
What were AYTU BioPharma, Inc.'s Q1 2026 revenue and EPS?
AYTU BioPharma, Inc. reported revenue of $16.1M and eps of $-0.05 for Q1 2026.
Did AYTU BioPharma, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $12.3M by $3.8M. EPS beat the consensus estimate of $-0.29 by $0.24.
How did AYTU BioPharma, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 12.7% from $18.5M a year earlier.
Where can I find AYTU BioPharma, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-030900) and the 10-Q periodic report (0001437749-26-016721) directly on SEC EDGAR. The filing index links above go to sec.gov.